UHS

+ Watchlist + Portfolio

Universal Health Services, Inc.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $172.33
52-Week Range: $140.08 – $246.33
Market Cap: $10.19B
P/E (TTM): 7.05
EPS (TTM): 24.51
Dividend Yield: 0.46%

Advanced Metrics

Price/Book: 1.36
PEG Ratio: 1.25
Return on Equity: 20.95%
Return on Assets: 8.32%
Gross Margin: 44.61%
Operating Margin: 11.14%
Profit Margin: 8.42%
Current Ratio: 1.12
Debt/Equity: 0.69
Total Debt: $5.26B
Free Cash Flow: $498.32M
Revenue Growth: 8.30%
Earnings Growth: 10.10%
Enterprise Value: $15.45B

UHS Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$13.40B	$14.28B	$15.83B	$17.36B
Cost of Revenue	$1.47B	$1.53B	$1.59B	$1.66B
Gross Profit	$11.93B	$12.75B	$14.24B	$15.71B
Selling, General & Admin	$6.89B	$7.25B	$7.67B	$8.23B
Operating Expenses	$10.92B	$11.57B	$12.56B	$13.71B
Operating Income	$1.00B	$1.18B	$1.68B	$1.99B
EBITDA	$1.58B	$1.72B	$2.27B	$2.74B
Pretax Income	$866.26M	$940.43M	$1.50B	$1.97B
Income Tax	$209.28M	$221.12M	$334.83M	$460.96M
Net Income	$675.61M	$717.79M	$1.14B	$1.49B
Diluted EPS	9.14	10.23	16.82	23.10
Diluted Shares	73.83M	70.13M	67.90M	64.46M

UHS Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$102.82M	$119.44M	$125.98M	$137.80M
Receivables	$2.02B	$2.24B	$2.18B	$2.60B
Inventory	$218.52M	$216.99M	$220.94M	$232.11M
Current Assets	$2.54B	$2.81B	$2.82B	$3.41B
Total Assets	$13.49B	$13.97B	$14.47B	$15.53B
Current Liabilities	$1.91B	$2.01B	$2.21B	$3.24B
Long-Term Debt	$4.73B	$4.79B	$4.46B	$4.00B
Total Debt	$5.27B	$5.37B	$4.96B	$5.17B
Total Liabilities	$7.52B	$7.77B	$7.71B	$8.12B
Retained Earnings	$6.53B	$6.80B	$7.37B	$7.99B
Shareholders' Equity	$5.92B	$6.15B	$6.67B	$7.28B
Working Capital	$622.92M	$798.00M	$605.88M	$168.31M
Net Debt	$4.71B	$4.79B	$4.38B	$4.61B

UHS Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	$996.02M	$1.27B	$2.07B	$1.86B
Capital Expenditure	-$734.00M	-$743.05M	-$943.81M	-$1.04B
Free Cash Flow	$262.02M	$524.74M	$1.12B	$824.55M
Depreciation & Amortisation	$581.86M	$568.04M	$584.83M	$618.74M
Stock-Based Compensation	$85.38M	$87.72M	$99.35M	$95.69M
Investing Cash Flow	-$647.30M	-$763.27M	-$911.11M	-$1.07B
Financing Cash Flow	-$318.40M	-$493.94M	-$1.14B	-$749.73M
Dividends Paid	-$58.45M	-$55.48M	-$53.35M	-$51.27M
Share Repurchases	-$832.92M	-$547.36M	-$670.75M	-$967.95M
Net Change in Cash	$30.33M	$10.58M	$11.12M	$44.05M

UHS Income statement, quarterly periods, in USD
USD	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Revenue	$4.28B	$4.50B	$4.49B	$4.50B	—
Cost of Revenue	$418.79M	$414.58M	$422.76M	$426.54M	—
Gross Profit	$3.87B	$4.08B	$4.06B	$4.07B	—
Selling, General & Admin	$2.05B	$2.11B	$2.09B	$2.13B	—
Operating Expenses	$3.36B	$3.56B	$3.55B	$3.57B	—
Operating Income	$500.27M	$521.69M	$517.23M	$502.86M	—
EBITDA	$659.85M	$689.32M	$785.99M	$660.51M	—
Pretax Income	$473.38M	$496.89M	$581.44M	$469.12M	—
Income Tax	$110.77M	$117.78M	$133.60M	$110.44M	—
Net Income	$353.22M	$372.96M	$445.94M	$348.68M	—
Diluted EPS	5.43	5.86	7.06	5.65	5.98
Diluted Shares	64.99M	63.66M	63.16M	61.67M	59.91M

UHS Balance Sheet statement, quarterly periods, in USD
USD	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Cash & Equivalents	$126.75M	$137.59M	$112.89M	$137.80M	$119.03M
Receivables	$2.41B	$2.30B	$2.59B	$2.60B	$2.75B
Inventory	$221.99M	$222.78M	$226.66M	$232.11M	$229.41M
Current Assets	$3.08B	$2.99B	$3.26B	$3.41B	$3.50B
Total Assets	$14.88B	$14.99B	$15.34B	$15.53B	$15.68B
Current Liabilities	$2.33B	$2.32B	$3.16B	$3.24B	$3.24B
Long-Term Debt	$4.61B	$4.54B	$3.95B	$4.00B	$3.95B
Total Debt	$5.09B	$5.01B	$5.11B	$5.17B	$5.13B
Total Liabilities	$7.99B	$7.84B	$8.05B	$8.12B	$8.08B
Retained Earnings	$7.49B	$7.71B	$7.87B	$7.99B	$8.20B
Shareholders' Equity	$6.79B	$7.03B	$7.17B	$7.28B	$7.46B
Working Capital	$747.12M	$672.91M	$98.77M	$168.31M	$255.62M
Net Debt	$4.52B	$4.45B	$4.58B	$4.61B	$4.59B

UHS Cash Flow statement, quarterly periods, in USD
USD	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Operating Cash Flow	$360.05M	$548.98M	$380.68M	$574.69M	$401.63M
Capital Expenditure	-$239.03M	-$266.01M	-$247.57M	-$287.24M	-$221.77M
Free Cash Flow	$121.02M	$282.96M	$133.11M	$287.45M	$179.86M
Depreciation & Amortisation	$148.34M	$152.00M	$155.06M	$163.33M	$155.43M
Stock-Based Compensation	$21.59M	$24.11M	$24.88M	$25.10M	$22.50M
Investing Cash Flow	-$271.30M	-$305.94M	-$269.41M	-$223.97M	-$197.58M
Financing Cash Flow	-$91.42M	-$227.65M	-$134.52M	-$296.13M	-$221.89M
Dividends Paid	-$13.53M	-$12.90M	-$12.47M	-$12.37M	-$12.97M
Share Repurchases	-$223.38M	-$155.16M	-$237.40M	-$352.01M	-$163.85M
Net Change in Cash	-$2.67M	$15.39M	-$23.26M	$54.59M	-$17.84M

Market Snapshot

About

Universal Health Services, Inc. owns and operates acute care hospitals, behavioral health centers, surgical hospitals, and ambulatory surgery centers across the United States and United Kingdom. The company is one of the largest hospital management companies in the nation. UHS provides a broad range of healthcare services including inpatient, outpatient, and emergency care.